Iannone Robert 4
4 · Jazz Pharmaceuticals plc · Filed Jan 22, 2025
Insider Transaction Report
Form 4
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
- Award
Ordinary Shares
2025-01-17+7,506→ 69,947 total - Tax Payment
Ordinary Shares
2025-01-17$122.62/sh−2,181$267,434→ 67,766 total
Footnotes (3)
- [F1]Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.
- [F2]The Reporting Person acquired 167 ordinary shares on May 31, 2024 and 48 ordinary shares on November 29, 2024 under a Section 423 Employee Stock Purchase Plan.
- [F3]Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.